Astellas Pharma and XenoPort have announced the introduction of Regnite (gabapentin enacarbil) extended-release tablets in Japan for the treatment of moderate-to-severe primary restless legs syndrome (RLS). Regnite, which was discovered ...
Tags: Rls Drug, Restless legs syndrome, Regnite extended-release tablets